The initial wave of excitement has now settled into a complex reality of access, affordability, and a sprawling, often confusing market
"For pharmaceutical executives, the lesson is clear: success in obesity will depend not only on science but also on vigilance, payer alignment, cultural reframing, and equitable access." The Evolution of Obesity Drugs: Lessons from a Century of Failures and the GLP-1 Breakthrough Thani Jambulingam, PhD The arrival of GLP-1 receptor agonists and dual agonists has delivered unprecedented efficacy, reframed obesity as a chronic disease, and sparked an industry gold rush
Small differences in BAC water volume completely change injection measurements, which is why dosage calculators are becoming increasingly important
It was approved by the US Food and Drug Administration in September 2019 for the treatment of adults with T2D and has since received approval from the European Medicines Agency
At room temperature, sulfur is a yellow crystalline solid, though it is found in nature more commonly in sulfide and sulfate mineral form
A.TschopM